v3.26.3
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]    
Gross sales $ 31,475,628 $ 29,100,391
Sales discounts & allowances (1,396,057) (1,431,497)
Revenue, net 30,079,571 27,668,894
Cost of goods sold 24,726,916 23,155,766
Depreciation and amortization 1,841,285 2,323,617
Total cost of goods sold 26,568,201 25,479,383
Gross profit 3,511,370 2,189,511
Total sales, general & administrative expenses 14,547,355 22,594,486
Loss from operations (11,035,985) (20,404,975)
Other income (expense):    
Impairment loss (2,007,438)
(Loss) gain on foreign exchange rates (15,943) 3,554
Interest expense (5,985,962) (5,060,678)
Total other expense (8,009,343) (5,057,124)
Loss before income taxes (19,045,328) (25,462,099)
Income tax benefit 66,710 134,901
Net loss $ (18,978,618) $ (25,327,198)
Loss per share from net loss    
Basic (in Dollars per share) $ (0.89) $ (1.25)
Diluted (in Dollars per share) [1] $ (0.89) $ (1.25)
Weighted average shares outstanding    
Basic (in Shares) 21,428,650 20,309,934
Diluted (in Shares) 21,428,650 20,309,934
[1] In periods where the Company has incurred a net loss, diluted earnings per share is based on the number of common shares issued and outstanding as including the effects of warrants would be anti-dilutive.